CJC1295/Ipamorelin

CJC-1295 is a 30 amino acid peptide hormone that has shown incredibly promising results as a Growth Hormone Releasing Hormone (GHRH) analog. CJC-1295 is often combined with Ipamorelin due to its enhanced specificity as a GHRH. CJC-1295/Ipamorelin stimulates Growth Hormone secretion and can provide a steady increase of growth Hormone with minimal effect on cortisol and prolactin levels. This means increased protein synthesis, thus promoting growth and fat loss simultaneously. Ipamorelin mimics ghrelin and binds to the ghrelin receptor in the brain, thereby selectively stimulating the release of GH from the pituitary gland. This results in increased plasma GH levels, which would affect many biological processes. Unlike other GH-releasing peptides, Ipamorelin only stimulates GH release in a manner very similar to that of Growth Hormone Releasing Hormone. This combination results increased energy, muscle mass, and stamina while generating better sleep.

Potential Side Effects

• Nausea

• Abdominal Pain

• Injection site reactions (irritation, erythema, induration, pain, itching)

• Diarrhea

• Vasodilation (flushing, warmth, transient hypotension)

Potential Benefits

• Increased protein synthesis

• Promotes fat burning

• Improves sleep quality

• Increased bone density

• Accelerated injury recovery

• Improved immune system

• Increased protein synthesis

• Increased energy

• Increase in lean body mass